Jun 12, 2017
LOS GATOS, CA (June 1, 2017) – Ximedica announced on Thursday that with immediate effect, in addition to her continuing corporate responsibilities, Tracy MacNeal will be taking over leadership of Ximedica’s Diagnostic Center of Excellence as President of XimedicaDx (formerly Accel Biotech).
“The Dx team is a passionate group with incredible capabilities in diagnostics technology. As XimedicaDx, together we can participate in a whole new level of project in Diagnostics, and as we grow our market share, our Dx team will go to a whole new level of accomplishment,” says Tracy MacNeal, President of XimedicaDx. “I’m excited about this new chapter for the whole Ximedica team.”
Tracy will lead the Dx team to enhance revenue growth, employee fulfilment, profitability, client satisfaction, and overall culture.
“This move helps us accelerate our integration of the Ximedica and Accel Biotech teams into One Ximedica,” says Randy Barko, CEO. “I’m excited to merge our Dx teams’ expertise in microfluidics, optics, automation, and robotics with the Ximedican brand of human-centric design, technical sophistication, and risk adverse regulatory rigor. With this combination, we can win large scale, leading-edge business in Diagnostics.”
Tracy and her family will be relocating from Rhode Island to California at the end of June. She will maintain her primary office in the Los Gatos facility.
Ximedica is a full-service ISO 13485-certified and FDA-registered product development firm. For 30 years Ximedica has provided a unique growth platform enabling organizations to successfully deploy medical technology products into the market. Its headquarters are in Providence, R.I., with offices in Hong Kong, Minneapolis, San Francisco and Los Gatos. In November of 2014, SV Life Sciences, a Boston-based private equity firm, acquired a majority stake in Ximedica, enabling the company to execute its growth strategy. www.ximedica.com